← Open Payments lookup

JESSE FISHMAN: Open Payments

NPI 1801490081 · BROOMFIELD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,657 in 122 payments from 22 companies in 2025. Trend: 2023 $22 · 2024 $1,076 · 2025 $2,657

Food & beverage: $2,657
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation20$400
AstraZeneca Pharmaceuticals LP13$390
GlaxoSmithKline, LLC.10$240
Regeneron Healthcare Solutions, Inc.10$192
Genentech USA, Inc.8$157
CSL Behring7$148
Amgen Inc.8$146
Cycle Pharmaceuticals Inc7$141
Grifols USA, LLC5$124
ARS Pharmaceuticals Operations, Inc.5$120

Products named: XOLAIR, TEZSPIRE, DUPIXENT, FASENRA, NUCALA, Sajazir, NEFFY, Prolastin-C Liquid.

Industry payments across CO — which companies pay providers there.